SRF 's Co-Managing Director has flagged uncertainty in the global market situation while projecting 15-20% growth for the next year, as highlighted in the company's latest concall update. The management acknowledged that the company's sales to West Asia have been adversely impacted, noting that the region was a key market for the company. Despite near-term headwinds, the optimistic growth outlook reflects management's confidence in navigating the ongoing geopolitical and macroeconomic challenges.

Global Market Uncertainty

SRF's Co-MD issued a warning regarding the prevailing uncertainty in the global market environment during the concall update. The cautionary commentary underscores management's recognition of the evolving macroeconomic and geopolitical landscape, which has begun to weigh on the company's international business operations.

West Asia Sales Headwinds

The Co-MD's remarks indicate that the geopolitical situation in West Asia has created tangible headwinds for SRF's sales. Management specifically identified West Asia as a key market for the company, underscoring the strategic importance of the region to SRF's export business. The acknowledgment from senior management highlights the significance of the disruption to the company's overall international revenue mix.

Management Outlook

Despite the near-term disruption to West Asia sales and the broader global market uncertainty, SRF's Co-MD expressed optimism about the company's future prospects, projecting 15-20% growth for the next year. Management's positive stance suggests confidence in the company's ability to navigate the ongoing geopolitical challenges and sustain its export business. The commentary reflects a measured assessment of current conditions while maintaining a constructive view on the company's trajectory.

SRF Limited has significantly enhanced its capital outlay for the establishment of fourth-generation refrigerant production facilities, revising the approved expenditure from ₹1,100 crores to ₹2,285 crores. The revision follows a change in project scope, as approved by the Board at its meeting held on May 5, 2026. The original capital expenditure of ₹1,100 crores had been sanctioned by the Board at its meeting on October 22, 2024.

Revised Capital Expenditure at a Glance

The key parameters of the revised capital expenditure are summarised below:

Expanded Project Scope

The revised project scope encompasses a broader range of manufacturing capabilities and infrastructure development. The three key components of the expanded project are:

• 20,000 MTPA Hydrofluoroolefins (HFOs) plants for the production of fourth-generation refrigerants
• 30,000 MTPA Anhydrous Hydrogen Fluoride (AHF) plant, along with forward integration into Value-added Hydrogen Fluoride (VHF) products
• Development of necessary utilities and infrastructure to support the above facilities at the proposed site in Gopalpur, Odisha

Strategic Rationale

The enhanced investment is driven by the anticipated demand for HFOs and VHF products. The project is aligned with the Company's strategic objective of strengthening its position in next-generation refrigerants and integrated fluorochemical value chains. The facilities are to be financed through a combination of debt and internal accruals, with completion targeted by February 28, 2028.